logo
  

L Brands Posts Q2 Loss

L Brands Inc. (LB), the parent company of Victoria's Secret brand, Wednesday posted a loss for the second quarter compared to a profit last year, as revenues plunged 20% hurt largely by coronavirus pandemic.

Columbus, Ohio-based L Brands reported second -quarter loss of $49.597 million or $0.18 per share, compared to profit of $37.596 million or $0.14 per share last year.

Adjusted earnings for the second quarter were $0.25 per share, up from $0.24 per share last year. On average, 26 analysts polled by Thomson Reuters estimated loss of $0.42 per share for the quarter.

L Brands' sales for the quarter plunged 20% $2.319 billion from $2.902 billion last year. Analysts had a consensus revenue estimate of $2.21 billion for the quarter.

As of the end of the second quarter, most Bath & Body Works and Victoria's Secret stores in North America have reopened.

Total Bath & Body Works sales in the United States and Canada were $1.197 billion, an increase of 13%, while Bath & Body Works direct business, which remained open throughout the quarter, increased by 191% to $518.6 million.

Total Victoria's Secret second quarter sales in the United States and Canada were $977.5 million, a decrease of 39%, while Victoria's Secret direct business, which remained open throughout the quarter, increased by 65% to $613.9 million.

LB closed Wednesday's trading at $28.47, up $0.29 or 1.03%, on the NYSE. The stock further gained $0.03 or $0.11 in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing. Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million... Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.
RELATED NEWS
Follow RTT